Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by lscfaon Mar 03, 2022 11:49am
114 Views
Post# 34479374

RE:RE:RE:5 NEW CONTRACTS/2500 PATIENTS TO BEGIN BOARDING IN APRIL2022

RE:RE:RE:5 NEW CONTRACTS/2500 PATIENTS TO BEGIN BOARDING IN APRIL2022

an alternative scenario is cyq1 has a large revenue bump due to a one-time hardware sale and then cyq2 revenues actually are lower than cyq1.    



lscfa wrote: If the $40 million revenue guidance is achieved for C2022 it will be mostly in Q3 and Q4. I expect  Jan/Feb/mar qtr to disappoint because co. keeps repeating that it's run rate at Dec 31/21 was $2 million/month but that is a bogus no. because revenue generation starts 2 to 3 months later.

When we talk about revenue recognition when we report revenue in the financials, so sales, this is sales revenue that has been recognized. And revenue is typically expected to be recognized within two to three months of onboarding of a patient onto our platform. So in the first two to threemonths, the first month, full month that a patient is on the platform is not billable, per Medicare and Medicaid. So that's a constraint that we can't get around. That's just part of the way that this business -- this industry is structured.

 

<< Previous
Bullboard Posts
Next >>